3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
52
Pancreatic Neoplasms
34
Colonic Neoplasms
20
Carcinoma, Hepatocellular
20
Esophageal Neoplasms
15
Neoplasms
14
Breast Neoplasms
12
Gastrointestinal Neoplasms
11
Stomach Neoplasms
10
Liver Neoplasms
10
Rectal Neoplasms
9
Lung Neoplasms
8
Head and Neck Neoplasms
7
Fibrosis
6
Biliary Tract Neoplasms
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Neoplasm, Residual
4
Neoplasm Metastasis
4
Gastrointestinal Stromal Tumors
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Pancreatic Cyst
3
Melanoma
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Cachexia
3
Sarcoma
2
Prostatic Neoplasms
2
Pancreatic Diseases
2
Interventions
pembrolizumab
1
Imatinib Mesylate
1
Histamine H2 Antagonists
1
HhAntag691
1
Famotidine
1
Cyclophosphamide
1
Blood Specimen Collection
1
Angptl4 protein, mouse
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dermatofibrosarcoma
×
Blood Specimen Collection
×
Gastrointestinal
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled